Workflow
OrthoPediatrics(KIDS)
icon
Search documents
OrthoPediatrics(KIDS) - 2019 Q2 - Quarterly Report
2019-08-13 18:43
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) FORM 10-Q For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission file number: 001-38242 OrthoPediatrics Corp. (Exact name of registrant as specified in its charter) (State or other jurisdiction ...
OrthoPediatrics(KIDS) - 2019 Q2 - Earnings Call Transcript
2019-08-10 16:44
OrthoPediatrics Corp (NASDAQ:KIDS) Q2 2019 Earnings Conference Call August 8, 2019 8:00 AM ET Company Participants Tram Bui - The Ruth Group Mark Throdahl - President, CEO & Director Fred Hite - CFO & Director Conference Call Participants Frederick Wise - Stifel, Nicolaus & Company Kevin Farshchi - Piper Jaffray Companies Anna Nussbaum - William Blair & Company Samuel Brodovsky - BTIG David Saxon - Needham & Company Jonathan Braatz - Kansas City Capital Associates Operator Good morning, ladies and gentlemen ...
OrthoPediatrics(KIDS) - 2019 Q1 - Quarterly Report
2019-05-09 16:14
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 For the transition period from _______ to _______ Commission file number: 001-38242 OrthoPediatrics Corp. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number) FORM 10-Q (Mark One) ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR ¨ TRANSITION REP ...
OrthoPediatrics(KIDS) - 2018 Q4 - Annual Report
2019-03-07 17:38
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K [Mark One] [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission file number 001-38242 ORTHOPEDIATRICS CORP. (Exact name of registrant as specified in its charter) Delaware 26-1761833 (State or ot ...